Regulation of influenza A virus mRNA splicing by CLK1

Influenza A virus carries eight negative single-stranded RNAs and uses spliced mRNAs to increase the number of proteins produced from them. Several genome-wide screens for essential host factors for influenza A virus replication revealed a necessity for splicing and splicing-related factors, includi...

Full description

Bibliographic Details
Main Authors: Artarini, A, Meyer, M, Shin, Y, Huber, K, Hilz, N, Bracher, F, Eros, D, Orfi, L, Keri, G, Goedert, S, Neuenschwander, M, Von Kries, J, Domovich-Eisenberg, Y, Dekel, N, Szabadkai, I, Lebendiker, M, Horváth, Z, Danieli, T, Livnah, O, Moncorgé, O, Frise, R, Barclay, W, Meyer, T, Karlas, A
Format: Journal article
Language:English
Published: Elsevier 2019
_version_ 1797075753537372160
author Artarini, A
Meyer, M
Shin, Y
Huber, K
Hilz, N
Bracher, F
Eros, D
Orfi, L
Keri, G
Goedert, S
Neuenschwander, M
Von Kries, J
Domovich-Eisenberg, Y
Dekel, N
Szabadkai, I
Lebendiker, M
Horváth, Z
Danieli, T
Livnah, O
Moncorgé, O
Frise, R
Barclay, W
Meyer, T
Karlas, A
author_facet Artarini, A
Meyer, M
Shin, Y
Huber, K
Hilz, N
Bracher, F
Eros, D
Orfi, L
Keri, G
Goedert, S
Neuenschwander, M
Von Kries, J
Domovich-Eisenberg, Y
Dekel, N
Szabadkai, I
Lebendiker, M
Horváth, Z
Danieli, T
Livnah, O
Moncorgé, O
Frise, R
Barclay, W
Meyer, T
Karlas, A
author_sort Artarini, A
collection OXFORD
description Influenza A virus carries eight negative single-stranded RNAs and uses spliced mRNAs to increase the number of proteins produced from them. Several genome-wide screens for essential host factors for influenza A virus replication revealed a necessity for splicing and splicing-related factors, including Cdc-like kinase 1 (CLK1). This CLK family kinase plays a role in alternative splicing regulation through phosphorylation of serine-arginine rich (SR) proteins. To examine the influence that modulation of splicing regulation has on influenza infection, we analyzed the effect of CLK1 knockdown and inhibition. CLK1 knockdown in A549 cells reduced influenza A/WSN/33 virus replication and increased the level of splicing of segment 7, which encodes the viral M1 and M2 proteins. CLK1-/- mice infected with influenza A/England/195/2009 (H1N1pdm09) virus supported lower levels of virus replication than wild-type mice. Screening of newly developed CLK inhibitors revealed several compounds that have an effect on the level of splicing of influenza A gene segment M in different models and decrease influenza A/WSN/33 virus replication in A549 cells. The promising inhibitor KH-CB19, an indole-based enaminonitrile with unique binding mode for CLK1, and its even more selective analogue NIH39 showed high specificity towards CLK1 and had a similar effect on influenza mRNA splicing regulation. Taken together, our findings indicate that targeting host factors that regulate splicing of influenza mRNAs may represent a novel therapeutic approach.
first_indexed 2024-03-06T23:54:40Z
format Journal article
id oxford-uuid:73cbcc6f-9036-4adc-bd13-5a131a9be6d8
institution University of Oxford
language English
last_indexed 2024-03-06T23:54:40Z
publishDate 2019
publisher Elsevier
record_format dspace
spelling oxford-uuid:73cbcc6f-9036-4adc-bd13-5a131a9be6d82022-03-26T19:58:43ZRegulation of influenza A virus mRNA splicing by CLK1Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:73cbcc6f-9036-4adc-bd13-5a131a9be6d8EnglishSymplectic Elements at OxfordElsevier2019Artarini, AMeyer, MShin, YHuber, KHilz, NBracher, FEros, DOrfi, LKeri, GGoedert, SNeuenschwander, MVon Kries, JDomovich-Eisenberg, YDekel, NSzabadkai, ILebendiker, MHorváth, ZDanieli, TLivnah, OMoncorgé, OFrise, RBarclay, WMeyer, TKarlas, AInfluenza A virus carries eight negative single-stranded RNAs and uses spliced mRNAs to increase the number of proteins produced from them. Several genome-wide screens for essential host factors for influenza A virus replication revealed a necessity for splicing and splicing-related factors, including Cdc-like kinase 1 (CLK1). This CLK family kinase plays a role in alternative splicing regulation through phosphorylation of serine-arginine rich (SR) proteins. To examine the influence that modulation of splicing regulation has on influenza infection, we analyzed the effect of CLK1 knockdown and inhibition. CLK1 knockdown in A549 cells reduced influenza A/WSN/33 virus replication and increased the level of splicing of segment 7, which encodes the viral M1 and M2 proteins. CLK1-/- mice infected with influenza A/England/195/2009 (H1N1pdm09) virus supported lower levels of virus replication than wild-type mice. Screening of newly developed CLK inhibitors revealed several compounds that have an effect on the level of splicing of influenza A gene segment M in different models and decrease influenza A/WSN/33 virus replication in A549 cells. The promising inhibitor KH-CB19, an indole-based enaminonitrile with unique binding mode for CLK1, and its even more selective analogue NIH39 showed high specificity towards CLK1 and had a similar effect on influenza mRNA splicing regulation. Taken together, our findings indicate that targeting host factors that regulate splicing of influenza mRNAs may represent a novel therapeutic approach.
spellingShingle Artarini, A
Meyer, M
Shin, Y
Huber, K
Hilz, N
Bracher, F
Eros, D
Orfi, L
Keri, G
Goedert, S
Neuenschwander, M
Von Kries, J
Domovich-Eisenberg, Y
Dekel, N
Szabadkai, I
Lebendiker, M
Horváth, Z
Danieli, T
Livnah, O
Moncorgé, O
Frise, R
Barclay, W
Meyer, T
Karlas, A
Regulation of influenza A virus mRNA splicing by CLK1
title Regulation of influenza A virus mRNA splicing by CLK1
title_full Regulation of influenza A virus mRNA splicing by CLK1
title_fullStr Regulation of influenza A virus mRNA splicing by CLK1
title_full_unstemmed Regulation of influenza A virus mRNA splicing by CLK1
title_short Regulation of influenza A virus mRNA splicing by CLK1
title_sort regulation of influenza a virus mrna splicing by clk1
work_keys_str_mv AT artarinia regulationofinfluenzaavirusmrnasplicingbyclk1
AT meyerm regulationofinfluenzaavirusmrnasplicingbyclk1
AT shiny regulationofinfluenzaavirusmrnasplicingbyclk1
AT huberk regulationofinfluenzaavirusmrnasplicingbyclk1
AT hilzn regulationofinfluenzaavirusmrnasplicingbyclk1
AT bracherf regulationofinfluenzaavirusmrnasplicingbyclk1
AT erosd regulationofinfluenzaavirusmrnasplicingbyclk1
AT orfil regulationofinfluenzaavirusmrnasplicingbyclk1
AT kerig regulationofinfluenzaavirusmrnasplicingbyclk1
AT goederts regulationofinfluenzaavirusmrnasplicingbyclk1
AT neuenschwanderm regulationofinfluenzaavirusmrnasplicingbyclk1
AT vonkriesj regulationofinfluenzaavirusmrnasplicingbyclk1
AT domovicheisenbergy regulationofinfluenzaavirusmrnasplicingbyclk1
AT dekeln regulationofinfluenzaavirusmrnasplicingbyclk1
AT szabadkaii regulationofinfluenzaavirusmrnasplicingbyclk1
AT lebendikerm regulationofinfluenzaavirusmrnasplicingbyclk1
AT horvathz regulationofinfluenzaavirusmrnasplicingbyclk1
AT danielit regulationofinfluenzaavirusmrnasplicingbyclk1
AT livnaho regulationofinfluenzaavirusmrnasplicingbyclk1
AT moncorgeo regulationofinfluenzaavirusmrnasplicingbyclk1
AT friser regulationofinfluenzaavirusmrnasplicingbyclk1
AT barclayw regulationofinfluenzaavirusmrnasplicingbyclk1
AT meyert regulationofinfluenzaavirusmrnasplicingbyclk1
AT karlasa regulationofinfluenzaavirusmrnasplicingbyclk1